# Comparison of Three Lancing Devices Regarding Capillary Blood Volume and Lancing Pain Intensity.

> **NCT03479619** · NA · COMPLETED · sponsor: **HTL-Strefa S.A.** · enrollment: 90 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** Lancing device A
- **DEVICE:** Lancing device B
- **DEVICE:** Lancing device C
- **DEVICE:** 28 G lancet
- **DEVICE:** 30 G lancet
- **DEVICE:** 33 G lancet
- **OTHER:** Lancing depth setting (1)
- **OTHER:** Lancing depth setting (5)

## Key facts

- **NCT ID:** NCT03479619
- **Lead sponsor:** HTL-Strefa S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-06
- **Primary completion:** 2018-05-14
- **Final completion:** 2018-09-27
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2020-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03479619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03479619, "Comparison of Three Lancing Devices Regarding Capillary Blood Volume and Lancing Pain Intensity.". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03479619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*